PharmTech Drug Digest 11.20
|Articles|November 19, 2009

AAPS 2009: Innovations-Neotanshinlactone Derivatives

A Joint Presentation of Pharmaceutical Technology and

Young Innovators of 2009: Interviews with AAPS Graduate Student Winners

Neotanshinlactone Derivatives

Subscribe to RSS feed of this series


Yizhou Dong
University of North Carolina, Chapel Hill


Category: DRUG DESIGN AND DISCOVERY


Design, Synthesis, and Biological Evaluation of Novel Neotanshinlactone Derivatives as Potent and Selective Anti-Breast Cancer Agents

View Poster Presentation

Related Articles

Related to this article

Green Chemistry Supply and Demand in Sustainable Pharma
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.